Skip to content

ClinChoice Belgium

Active
Private limited companyfounded 1994active for 32 yearsSteenweg op Mechelen 455, 1950 Kraainem, BelgiumKBO/BCE: BE 0452.023.661
Summary

The annual accounts of ClinChoice Belgium for financial year 2025 show a net loss of 56% of the equity at the start of that year. The 2025 annual accounts show equity of €177,888 and a net result of -€227,259. Equity has been stable since 2018 (±1.5% per year). Its solvency ranks better than 12% of 3,032 sector peers (NACE 86, financial year 2025). The company has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Official details

Source: KBO
Status
Active since 07-03-1994 Normal situation
Registered office
961 active companies are registered at this address 95 started in the 12 months before. Source: KBO register, as of 2 November 2026.
Activity
Specialist medical practice NACE 86220and 2 others
Joint committees
116 Paritair Comité voor de scheikundige nijverheid
207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2025
Establishment unit
2.065.915.601 1950 Kraainem, since 22-03-2001
Financial year end
31 December
Peppol
Reachable since 12-11-2025

Board and ownership

Board
  • Xin KEDirector · since 16-12-2024
Auditor
Bv Robrechts Lenaerts Bedrijfsrevisoren - Réviseurs d'entreprises
Shareholders
  • ClinChoice Srlannual accounts 2025
Holdings
Shares in 1 company ClinChoice Netherlands Bv

Financial position

52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Annual accounts 2025
Gross margin
€1.8m
▼ 26.1%
Turnover
≈ €1.6m
estimated
Loss
€227,259
▲ 956%
Equity
€177,888
▼ 56.1%
Total assets
€2.6m
▼ 13.0%
Employees on 31-12-2025
21
▼ 8.7%
  • 2025 accounts filed 61 days after the deadline
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €227,259, the second in a row (financial year 2025)Last filed accounts filed 61 days late; 3 of the last 3 accounts lateEquity €177,888 (6.9% of total assets)lowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 3% of small companies in human health (NACE 86)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 32-7
equity 6.9% of total assets
Liquidity 11-11
short-term debt 90.7% · cash 8.5%
Profitability 16-20
return on assets -8.8%
Bankruptcy probability within 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,079 companies, NACE 86, small)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024lowest value 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025 08-2025: 0.6%▲ +0.1 percentage points vs 07-2025 09-2025: 0.8%▲ +0.2 percentage points vs 08-2025 10-2025: 0.4%▼ -0.4 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.6%▲ +0.2 percentage points vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.5%▼ -0.1 percentage points vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.6%▲ +0.1 percentage points vs 06-2026 08-2026: 0.8%▲ +0.2 percentage points vs 07-2026 09-2026: 0.9%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.8%▼ -0.1 percentage points vs 09-2026 11-2026: 0.8%● unchanged vs 10-2026
Credit of up to €9,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity is insufficient, with a current ratio of 0.92 (1.18 in 2024), below 1. Short-term debt is 90.7% and cash 8.5% of total assets. 93.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 6% of them on solvency, 1% on liquidity, 5% on profitability and 2% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Loss of €227,259, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Last filed accounts filed 61 days late; 3 of the last 3 accounts late
NBB · filings
raises risk · Equity €177,888 (6.9% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€227,259
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 3032 sector peers (2025).
NBB · sector comparison
Position among 3032 sector peers
Solvency
better than 12%
← weakest strongest →
raises risk · 2025 accounts filed 61 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
61 days late
2024
47 days late
2023
43 days late
2022
6 days early
2021
30 days late
2020
6 days late
2019
48 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 33 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2025from -€21,530 to -€227,259 ▼ 956% View
  • Caution: Lower net result than 95% of companies in human healthsector median €110,426 · 2,998 companies -€227,259 View
  • Caution: 2 loss-making years in a rowloss in financial year 2025 -€227,259 View

Recent changes

  1. · Gazette deed Company renamed from CROMSOURCE to ClinChoice Belgium
  2. · Gazette deed Appointment: Xin KE (director)Resignation: Oriana ZERBINI (director)
  3. · Gazette deed Resignation: Carlo ZERBINI (director)
All 20 events

Comparable companies

These companies have the same main activity as ClinChoice Belgium: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.6m and €3.6m, founded between 1988 and 2006.

CompanyTotal assetsGross margin
ClinChoice Belgium Kraainem€2.6m€1.8m
BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT Genk€3.0m€2.4m
EVENS OCULAR ASSOCIATES Wemmel€3.6m€2.6m
Maison médicale Saint Léonard Centre de Santé intégré asbl Liège€1.9m€2.0m
Centrum voor Ontwikkelingsstoornissen-Gent Gent€2.2m€2.9m
OOGINSTITUUT Aalst€2.4m€2.8m
Centre de Santé du Namurois - Réseau Solidaris Namur€1.6m€1.0m
Full comparison

Key facts about ClinChoice Belgium

What is the company number of ClinChoice Belgium?
The company number of ClinChoice Belgium is 0452.023.661. The VAT number is the same number with BE in front: BE 0452.023.661.
Where is ClinChoice Belgium based?
The registered office is at Steenweg op Mechelen 455, 1950 Kraainem.Company details
What does ClinChoice Belgium do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ClinChoice Belgium?
The legal form of ClinChoice Belgium is Private limited company (BV).
When was ClinChoice Belgium founded?
ClinChoice Belgium was founded on 07-03-1994.
Is ClinChoice Belgium still active?
Yes, ClinChoice Belgium is an active enterprise in the KBO register.
How many employees does ClinChoice Belgium have?
ClinChoice Belgium had an average of 20.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does ClinChoice Belgium fall under?
In its 2025 annual accounts, ClinChoice Belgium states joint committees 116 (Paritair Comité voor de scheikundige nijverheid) and 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
What is the turnover of ClinChoice Belgium?
The turnover in financial year 2025 is ≈ €1.6m. This figure is estimated from the gross margin of €1.8m and 64 comparable companies (NACE 86). It probably lies between €1.5m and €2.4m. In financial year 2019 turnover was €6.1m.
Is ClinChoice Belgium profitable?
In financial year 2025, ClinChoice Belgium made a loss of €227,259.
Where can I find the annual accounts of ClinChoice Belgium?
ClinChoice Belgium filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ClinChoice Belgium due?
ClinChoice Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.